Bio 33 15 Mar 27 Bond Number Of Shares Shorted
| 090572AR9 | 93.40 3.51 3.62% |
BIO 33 15 MAR 27 fundamentals help investors to digest information that contributes to 090572AR9's financial success or failures. It also enables traders to predict the movement of 090572AR9 Bond. The fundamental analysis module provides a way to measure 090572AR9's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to 090572AR9 bond.
090572AR9 |
BIO 33 15 MAR 27 Corporate Bond Number Of Shares Shorted Analysis
090572AR9's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Based on the recorded statements, BIO 33 15 MAR 27 has 0.0 of outstending shares currently sold short by investors. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Number Of Shares Shorted (which currently averages 0.0) industry. This indicator is about the same for all United States bonds average (which is currently at 0.0).
090572AR9 Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 090572AR9's direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the bonds which would be a good addition to a portfolio. Peer analysis of 090572AR9 could also be used in its relative valuation, which is a method of valuing 090572AR9 by comparing valuation metrics of similar companies.BIO 33 cannot be rated in Number Of Shares Shorted category at this point.
About 090572AR9 Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BIO 33 15 MAR 27's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 090572AR9 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BIO 33 15 MAR 27 based on its fundamental data. In general, a quantitative approach, as applied to this corporate bond, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in 090572AR9 Bond
090572AR9 financial ratios help investors to determine whether 090572AR9 Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 090572AR9 with respect to the benefits of owning 090572AR9 security.